Biomarkers in congenital heart disease: do natriuretic peptides hold the key?

Author： Alonso-Gonzalez Rafael   Dimopoulos Konstantinos  

Publisher： Informa Healthcare

ISSN： 1477-9072

Source： Expert Review of Cardiovascular Therapy, Vol.11, Iss.6, 2013-06, pp. : 773-784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The natriuretic peptides in heart failure

By Richards A.  

Basic Research in Cardiology, Vol. 99, Iss. 2, 2004-03 ,pp. : 94-100

Springer Publishing Company

Access to resources Recommend Favorite

Natriuretic Peptides in Health and Disease

By Kelley T.J.   Drumm M.L.  

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 2, 1999-03 ,pp. : 78-79

Elsevier

Access to resources Recommend Favorite

Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin

By Palazzuoli Alberto   Masson Serge   Ronco Claudio   Maisel Alan  

Heart Failure Reviews, Vol. 19, Iss. 2, 2014-03 ,pp. : 267-284

Springer Publishing Company

Access to resources Recommend Favorite

Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?

By Gehrau Ricardo C   Mas Valeria R   Maluf Daniel G  

Expert Review of Gastroenterology and Hepatology, Vol. 7, Iss. 2, 2013-02 ,pp. : 157-170

Informa Healthcare

Access to resources Recommend Favorite

Human myocardial grafts: do they meet all the criteria for true heart regeneration?

By Futakuchi-Tsuchida Akiko   Murry Charles E  

Future Cardiology, Vol. 9, Iss. 2, 2013-03 ,pp. : 151-154

Future Medicine

Access to resources Recommend Favorite